631-01-6

Basic information

• Product Name: Quillaic acid
• Synonyms: (3beta,4alpha,16alpha)-3,16-dihydroxy-23-oxoolean-12-en-28-oic acid;Olean-12-en-28-oic acid, 3,16-dihydroxy-23-oxo-, (3.beta.,4.alpha.,16.alpha.)-;quillaic acid;QUILLAJAEXTRACTS;QUILLAIAEXTRACTS;EXTRACTOFQUILLAIA;QUILLAIA;(4S)-3β,16α-Dihydroxy-23-oxoolean-12-en-28-oic acid
• CAS NO: 631-01-6
• Molecular Formula: C₃₀H₄₆O₅
• Molecular Weight: 486.68324
• EINECS: 211-149-8
• Mol File: 631-01-6.mol
• Article Data: 9

Chemical Properties

• Melting Point: 294℃
• Boiling Point: 502.54°C (rough estimate)
• Flash Point: 338.716 °C
• Appearance: /
• Density: 1.0220 (rough estimate)
• Vapor Pressure: 1.33E-17mmHg at 25°C
• Refractive Index: 1.5800 (estimate)
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: Acetone (Slightly), DMSO (Slightly), Methanol (Slightly), Pyridine (Slightly)
• PKA: 4.41±0.70(Predicted)
• CAS DataBase Reference: Quillaic acid(CAS DataBase Reference)
• NIST Chemistry Reference: Quillaic acid(631-01-6)
• EPA Substance Registry System: Quillaic acid(631-01-6)

Safety Data

• Hazardous Substances Data: 631-01-6(Hazardous Substances Data)

Usage

Description

Quillaic acid is an unglycosylated saponin derived from the Quillaja saponaria bark, which possesses anti-inflammatory properties.

Uses

Used in Pharmaceutical Industry:
Quillaic acid is used as a topical anti-inflammatory agent for its ability to reduce inflammation and provide relief from various skin conditions and irritations.

InChI:InChI=1/C30H46O5/c1-25(2)13-14-30(24(34)35)19(15-25)18-7-8-21-26(3)11-10-22(32)27(4,17-31)20(26)9-12-28(21,5)29(18,6)16-23(30)33/h7,17,19-23,32-33H,8-16H2,1-6H3,(H,34,35)/t19-,20+,21+,22-,23+,26-,27-,28+,29+,30+/m0/s1

Upstream product

• 1248822-15-2 quillaic acid 3-O-β-D-xylopyranosyl-(1->3)-β-D-glucuronopyranoside 
• 1248822-17-4 3-O-β-D-galactopyranosyl-(1->2)-[β-D-xylopyranosyl-(1->3)]-β-D-glucuronopyranosyl quilliac acid 28-O-(6-O-acetyl)-β-D-glucopyranosyl-(1->3)-[β-D-xylopyranosyl-(1->4)]-α-L-rhamnopyranosyl-(1->2)-β-D-fucopyranoside 
• 96552-98-6 C₄₉H₇₆O₂₀ 
• 2627-86-3 (S)-1-phenyl-ethylamine 
• 108-24-7 acetic anhydride 
• 1028100-28-8 quillaic acid 3-O-β-D-galactopyranosyl-(1->2)-[β-D-galactopyranosyl-(1->3)]-β-D-glucuronopyranoside 
• 97892-86-9 <16,28-dihydroxy-23,28-dioxoolean-12-en-3β-yl O-β-D-galactopyranosyl-(1->2)-O-β-D-xylopyranosyl-(1->3)-β-D-glucopyranosid>uronic 
• 107091-09-8 3-O-β-D-galactopyranosyl-(1->2)-<β-D-xylopyranosyl-(1->3)>-β-D-glucuronopyranosyl quillaic acid 28-O-β-D-apiofuranosyl-(1->3)-β-D-xylopyranosyl-(1->4)-<β-D-glucopyranosyl-(1->3)>-α-L-rhamnopyranosyl-(1->2)-β-D-fucopyranoside. 

Downstream Products

• 486-34-0 1,2,7-trimethylnaphthalene 
• 52936-64-8 3β,16α,23-trihydroxyolean-12-en-28-oic acid 

Relevant articles and documents

TRITERPENE SAPONIN ANALOGUES

The present application relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, and intermediates thereto. The application also provides pharmaceutical compositions comprising compounds of the present invention and methods of using said compounds or compositions in the treatment of and immunization for infectious diseases.

New triterpenoid saponins from the roots of Gypsophila pacifica Kom.

Six new triterpenoid saponins (1-6) have been isolated from the roots of Gypsophila pacifica Kom. Their structures were established on the basis of extensive NMR (1H, 13C, TOCSY, HSQC, and HMBC) and ESIMS studies.